カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のプロトオンコジーンチロシンプロテインキナーゼSrc市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Proto Oncogene Tyrosine Protein Kinase Src Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19578）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19578
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のプロトオンコジーンチロシンプロテインキナーゼSrc市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

プロトオンコジーンチロシンプロテインキナーゼSrc市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のプロトオンコジーンチロシンプロテインキナーゼSrcの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

プロトオンコジーンチロシンプロテインキナーゼSrc市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・プロトオンコジーン c Src、Pp60c src、SRC、EC 2.7.10.2

用途別セグメントは次のように区分されます。
・がん、呼吸器、中枢神経、消化器、遺伝性疾患、感染症、筋骨格疾患、眼科

世界のプロトオンコジーンチロシンプロテインキナーゼSrc市場の主要な市場プレーヤーは以下のとおりです。
・AbbVie Inc、AstraZeneca Plc、Avalyn Pharma Inc、Boehringer Ingelheim International GmbH、KeifeRx LLC、Lead Discovery Center GmbH、Taiwan Liposome Co Ltd、TopiVert Ltd、Turning Point Therapeutics Inc

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、プロトオンコジーンチロシンプロテインキナーゼSrc製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なプロトオンコジーンチロシンプロテインキナーゼSrcメーカーの企業概要、2019年～2022年までのプロトオンコジーンチロシンプロテインキナーゼSrcの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なプロトオンコジーンチロシンプロテインキナーゼSrcメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別プロトオンコジーンチロシンプロテインキナーゼSrcの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのプロトオンコジーンチロシンプロテインキナーゼSrcの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのプロトオンコジーンチロシンプロテインキナーゼSrc市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびプロトオンコジーンチロシンプロテインキナーゼSrcの産業チェーンを掲載しています。
・第13、14、15章では、プロトオンコジーンチロシンプロテインキナーゼSrcの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- プロトオンコジーンチロシンプロテインキナーゼSrcの概要
- 種類別分析（2017年vs2021年vs2028年）：プロトオンコジーン c Src、Pp60c src、SRC、EC 2.7.10.2
- 用途別分析（2017年vs2021年vs2028年）：がん、呼吸器、中枢神経、消化器、遺伝性疾患、感染症、筋骨格疾患、眼科
- 世界のプロトオンコジーンチロシンプロテインキナーゼSrc市場規模・予測
- 世界のプロトオンコジーンチロシンプロテインキナーゼSrc生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- AbbVie Inc、AstraZeneca Plc、Avalyn Pharma Inc、Boehringer Ingelheim International GmbH、KeifeRx LLC、Lead Discovery Center GmbH、Taiwan Liposome Co Ltd、TopiVert Ltd、Turning Point Therapeutics Inc
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：プロトオンコジーン c Src、Pp60c src、SRC、EC 2.7.10.2
・用途別分析2017年-2028年：がん、呼吸器、中枢神経、消化器、遺伝性疾患、感染症、筋骨格疾患、眼科
・プロトオンコジーンチロシンプロテインキナーゼSrcの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・プロトオンコジーンチロシンプロテインキナーゼSrcのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・プロトオンコジーンチロシンプロテインキナーゼSrcのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・プロトオンコジーンチロシンプロテインキナーゼSrcの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・プロトオンコジーンチロシンプロテインキナーゼSrcの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Proto Oncogene Tyrosine Protein Kinase Src market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Proto Oncogene Tyrosine Protein Kinase Src market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Oncology accounting for % of the Proto Oncogene Tyrosine Protein Kinase Src global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Proto Oncogene c Src segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Proto Oncogene Tyrosine Protein Kinase Src include AbbVie Inc, AstraZeneca Plc, Avalyn Pharma Inc, Boehringer Ingelheim International GmbH, and KeifeRx LLC, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Proto Oncogene Tyrosine Protein Kinase Src market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Proto Oncogene c Src
Pp60c src
SRC
EC 2.7.10.2
Market segment by Application can be divided into
Oncology
Respiratory
Central Nervous System
Gastrointestinal
Genetic Disorders
Infectious Disease
Musculoskeletal Disorders
Ophthalmology
The key market players for global Proto Oncogene Tyrosine Protein Kinase Src market are listed below:
AbbVie Inc
AstraZeneca Plc
Avalyn Pharma Inc
Boehringer Ingelheim International GmbH
KeifeRx LLC
Lead Discovery Center GmbH
Taiwan Liposome Co Ltd
TopiVert Ltd
Turning Point Therapeutics Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Proto Oncogene Tyrosine Protein Kinase Src product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Proto Oncogene Tyrosine Protein Kinase Src, with price, sales, revenue and global market share of Proto Oncogene Tyrosine Protein Kinase Src from 2019 to 2022.
Chapter 3, the Proto Oncogene Tyrosine Protein Kinase Src competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Proto Oncogene Tyrosine Protein Kinase Src breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Proto Oncogene Tyrosine Protein Kinase Src market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Proto Oncogene Tyrosine Protein Kinase Src.
Chapter 13, 14, and 15, to describe Proto Oncogene Tyrosine Protein Kinase Src sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Proto Oncogene Tyrosine Protein Kinase Src Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Proto Oncogene c Src
1.2.3 Pp60c src
1.2.4 SRC
1.2.5 EC 2.7.10.2
1.3 Market Analysis by Application
1.3.1 Overview: Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Oncology
1.3.3 Respiratory
1.3.4 Central Nervous System
1.3.5 Gastrointestinal
1.3.6 Genetic Disorders
1.3.7 Infectious Disease
1.3.8 Musculoskeletal Disorders
1.3.9 Ophthalmology
1.4 Global Proto Oncogene Tyrosine Protein Kinase Src Market Size & Forecast
1.4.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Proto Oncogene Tyrosine Protein Kinase Src Sales in Volume (2017-2028)
1.4.3 Global Proto Oncogene Tyrosine Protein Kinase Src Price (2017-2028)
1.5 Global Proto Oncogene Tyrosine Protein Kinase Src Production Capacity Analysis
1.5.1 Global Proto Oncogene Tyrosine Protein Kinase Src Total Production Capacity (2017-2028)
1.5.2 Global Proto Oncogene Tyrosine Protein Kinase Src Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Proto Oncogene Tyrosine Protein Kinase Src Market Drivers
1.6.2 Proto Oncogene Tyrosine Protein Kinase Src Market Restraints
1.6.3 Proto Oncogene Tyrosine Protein Kinase Src Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie Inc
2.1.1 AbbVie Inc Details
2.1.2 AbbVie Inc Major Business
2.1.3 AbbVie Inc Proto Oncogene Tyrosine Protein Kinase Src Product and Services
2.1.4 AbbVie Inc Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AstraZeneca Plc
2.2.1 AstraZeneca Plc Details
2.2.2 AstraZeneca Plc Major Business
2.2.3 AstraZeneca Plc Proto Oncogene Tyrosine Protein Kinase Src Product and Services
2.2.4 AstraZeneca Plc Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Avalyn Pharma Inc
2.3.1 Avalyn Pharma Inc Details
2.3.2 Avalyn Pharma Inc Major Business
2.3.3 Avalyn Pharma Inc Proto Oncogene Tyrosine Protein Kinase Src Product and Services
2.3.4 Avalyn Pharma Inc Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Boehringer Ingelheim International GmbH
2.4.1 Boehringer Ingelheim International GmbH Details
2.4.2 Boehringer Ingelheim International GmbH Major Business
2.4.3 Boehringer Ingelheim International GmbH Proto Oncogene Tyrosine Protein Kinase Src Product and Services
2.4.4 Boehringer Ingelheim International GmbH Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 KeifeRx LLC
2.5.1 KeifeRx LLC Details
2.5.2 KeifeRx LLC Major Business
2.5.3 KeifeRx LLC Proto Oncogene Tyrosine Protein Kinase Src Product and Services
2.5.4 KeifeRx LLC Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Lead Discovery Center GmbH
2.6.1 Lead Discovery Center GmbH Details
2.6.2 Lead Discovery Center GmbH Major Business
2.6.3 Lead Discovery Center GmbH Proto Oncogene Tyrosine Protein Kinase Src Product and Services
2.6.4 Lead Discovery Center GmbH Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Taiwan Liposome Co Ltd
2.7.1 Taiwan Liposome Co Ltd Details
2.7.2 Taiwan Liposome Co Ltd Major Business
2.7.3 Taiwan Liposome Co Ltd Proto Oncogene Tyrosine Protein Kinase Src Product and Services
2.7.4 Taiwan Liposome Co Ltd Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 TopiVert Ltd
2.8.1 TopiVert Ltd Details
2.8.2 TopiVert Ltd Major Business
2.8.3 TopiVert Ltd Proto Oncogene Tyrosine Protein Kinase Src Product and Services
2.8.4 TopiVert Ltd Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Turning Point Therapeutics Inc
2.9.1 Turning Point Therapeutics Inc Details
2.9.2 Turning Point Therapeutics Inc Major Business
2.9.3 Turning Point Therapeutics Inc Proto Oncogene Tyrosine Protein Kinase Src Product and Services
2.9.4 Turning Point Therapeutics Inc Proto Oncogene Tyrosine Protein Kinase Src Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Proto Oncogene Tyrosine Protein Kinase Src Breakdown Data by Manufacturer
3.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Proto Oncogene Tyrosine Protein Kinase Src
3.4 Market Concentration Rate
3.4.1 Top 3 Proto Oncogene Tyrosine Protein Kinase Src Manufacturer Market Share in 2021
3.4.2 Top 6 Proto Oncogene Tyrosine Protein Kinase Src Manufacturer Market Share in 2021
3.5 Global Proto Oncogene Tyrosine Protein Kinase Src Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Proto Oncogene Tyrosine Protein Kinase Src Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Proto Oncogene Tyrosine Protein Kinase Src Market Size by Region
4.1.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales in Volume by Region (2017-2028)
4.1.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region (2017-2028)
4.2 North America Proto Oncogene Tyrosine Protein Kinase Src Revenue (2017-2028)
4.3 Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue (2017-2028)
4.4 Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue (2017-2028)
4.5 South America Proto Oncogene Tyrosine Protein Kinase Src Revenue (2017-2028)
4.6 Middle East and Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales in Volume by Type (2017-2028)
5.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type (2017-2028)
5.3 Global Proto Oncogene Tyrosine Protein Kinase Src Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Proto Oncogene Tyrosine Protein Kinase Src Sales in Volume by Application (2017-2028)
6.2 Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application (2017-2028)
6.3 Global Proto Oncogene Tyrosine Protein Kinase Src Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2017-2028)
7.2 North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2017-2028)
7.3 North America Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country
7.3.1 North America Proto Oncogene Tyrosine Protein Kinase Src Sales in Volume by Country (2017-2028)
7.3.2 North America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2017-2028)
8.2 Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2017-2028)
8.3 Europe Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country
8.3.1 Europe Proto Oncogene Tyrosine Protein Kinase Src Sales in Volume by Country (2017-2028)
8.3.2 Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2017-2028)
9.2 Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2017-2028)
9.3 Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Market Size by Region
9.3.1 Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2017-2028)
10.2 South America Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2017-2028)
10.3 South America Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country
10.3.1 South America Proto Oncogene Tyrosine Protein Kinase Src Sales in Volume by Country (2017-2028)
10.3.2 South America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2017-2028)
11.2 Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2017-2028)
11.3 Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Market Size by Country
11.3.1 Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Proto Oncogene Tyrosine Protein Kinase Src and Key Manufacturers
12.2 Manufacturing Costs Percentage of Proto Oncogene Tyrosine Protein Kinase Src
12.3 Proto Oncogene Tyrosine Protein Kinase Src Production Process
12.4 Proto Oncogene Tyrosine Protein Kinase Src Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Proto Oncogene Tyrosine Protein Kinase Src Typical Distributors
13.3 Proto Oncogene Tyrosine Protein Kinase Src Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Inc Major Business
Table 5. AbbVie Inc Proto Oncogene Tyrosine Protein Kinase Src Product and Services
Table 6. AbbVie Inc Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Plc Major Business
Table 9. AstraZeneca Plc Proto Oncogene Tyrosine Protein Kinase Src Product and Services
Table 10. AstraZeneca Plc Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Avalyn Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 12. Avalyn Pharma Inc Major Business
Table 13. Avalyn Pharma Inc Proto Oncogene Tyrosine Protein Kinase Src Product and Services
Table 14. Avalyn Pharma Inc Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 16. Boehringer Ingelheim International GmbH Major Business
Table 17. Boehringer Ingelheim International GmbH Proto Oncogene Tyrosine Protein Kinase Src Product and Services
Table 18. Boehringer Ingelheim International GmbH Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. KeifeRx LLC Basic Information, Manufacturing Base and Competitors
Table 20. KeifeRx LLC Major Business
Table 21. KeifeRx LLC Proto Oncogene Tyrosine Protein Kinase Src Product and Services
Table 22. KeifeRx LLC Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Lead Discovery Center GmbH Basic Information, Manufacturing Base and Competitors
Table 24. Lead Discovery Center GmbH Major Business
Table 25. Lead Discovery Center GmbH Proto Oncogene Tyrosine Protein Kinase Src Product and Services
Table 26. Lead Discovery Center GmbH Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Taiwan Liposome Co Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Taiwan Liposome Co Ltd Major Business
Table 29. Taiwan Liposome Co Ltd Proto Oncogene Tyrosine Protein Kinase Src Product and Services
Table 30. Taiwan Liposome Co Ltd Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. TopiVert Ltd Basic Information, Manufacturing Base and Competitors
Table 32. TopiVert Ltd Major Business
Table 33. TopiVert Ltd Proto Oncogene Tyrosine Protein Kinase Src Product and Services
Table 34. TopiVert Ltd Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Turning Point Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 36. Turning Point Therapeutics Inc Major Business
Table 37. Turning Point Therapeutics Inc Proto Oncogene Tyrosine Protein Kinase Src Product and Services
Table 38. Turning Point Therapeutics Inc Proto Oncogene Tyrosine Protein Kinase Src Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Proto Oncogene Tyrosine Protein Kinase Src, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Proto Oncogene Tyrosine Protein Kinase Src Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Proto Oncogene Tyrosine Protein Kinase Src Production Site of Key Manufacturer
Table 44. Proto Oncogene Tyrosine Protein Kinase Src New Entrant and Capacity Expansion Plans
Table 45. Proto Oncogene Tyrosine Protein Kinase Src Mergers & Acquisitions in the Past Five Years
Table 46. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region (2017-2022) & (K Units)
Table 47. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Region (2023-2028) & (K Units)
Table 48. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2017-2022) & (K Units)
Table 51. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2023-2028) & (K Units)
Table 52. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Proto Oncogene Tyrosine Protein Kinase Src Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Proto Oncogene Tyrosine Protein Kinase Src Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2017-2022) & (K Units)
Table 57. Global Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2023-2028) & (K Units)
Table 58. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Proto Oncogene Tyrosine Protein Kinase Src Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Proto Oncogene Tyrosine Protein Kinase Src Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2017-2022) & (K Units)
Table 63. North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2023-2028) & (K Units)
Table 64. North America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2017-2022) & (K Units)
Table 67. North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2023-2028) & (K Units)
Table 68. North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2017-2022) & (K Units)
Table 69. North America Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2023-2028) & (K Units)
Table 70. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2017-2022) & (K Units)
Table 71. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2023-2028) & (K Units)
Table 72. Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2017-2022) & (K Units)
Table 75. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2023-2028) & (K Units)
Table 76. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2017-2022) & (K Units)
Table 77. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2023-2028) & (K Units)
Table 86. South America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2017-2022) & (K Units)
Table 87. South America Proto Oncogene Tyrosine Protein Kinase Src Sales by Country (2023-2028) & (K Units)
Table 88. South America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Proto Oncogene Tyrosine Protein Kinase Src Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2017-2022) & (K Units)
Table 91. South America Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2023-2028) & (K Units)
Table 92. South America Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2017-2022) & (K Units)
Table 93. South America Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Sales by Application (2023-2028) & (K Units)
Table 102. Proto Oncogene Tyrosine Protein Kinase Src Raw Material
Table 103. Key Manufacturers of Proto Oncogene Tyrosine Protein Kinase Src Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Proto Oncogene Tyrosine Protein Kinase Src Typical Distributors
Table 107. Proto Oncogene Tyrosine Protein Kinase Src Typical Customers
List of Figures
Figure 1. Proto Oncogene Tyrosine Protein Kinase Src Picture
Figure 2. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Type in 2021
Figure 3. Proto Oncogene c Src
Figure 4. Pp60c src
Figure 5. SRC
Figure 6. EC 2.7.10.2
Figure 7. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Application in 2021
Figure 8. Oncology
Figure 9. Respiratory
Figure 10. Central Nervous System
Figure 11. Gastrointestinal
Figure 12. Genetic Disorders
Figure 13. Infectious Disease
Figure 14. Musculoskeletal Disorders
Figure 15. Ophthalmology
Figure 16. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 17. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue and Forecast (2017-2028) & (USD Million)
Figure 18. Global Proto Oncogene Tyrosine Protein Kinase Src Sales (2017-2028) & (K Units)
Figure 19. Global Proto Oncogene Tyrosine Protein Kinase Src Price (2017-2028) & (US$/Unit)
Figure 20. Global Proto Oncogene Tyrosine Protein Kinase Src Production Capacity (2017-2028) & (K Units)
Figure 21. Global Proto Oncogene Tyrosine Protein Kinase Src Production Capacity by Geographic Region: 2022 VS 2028
Figure 22. Proto Oncogene Tyrosine Protein Kinase Src Market Drivers
Figure 23. Proto Oncogene Tyrosine Protein Kinase Src Market Restraints
Figure 24. Proto Oncogene Tyrosine Protein Kinase Src Market Trends
Figure 25. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Manufacturer in 2021
Figure 26. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Manufacturer in 2021
Figure 27. Proto Oncogene Tyrosine Protein Kinase Src Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 28. Top 3 Proto Oncogene Tyrosine Protein Kinase Src Manufacturer (Revenue) Market Share in 2021
Figure 29. Top 6 Proto Oncogene Tyrosine Protein Kinase Src Manufacturer (Revenue) Market Share in 2021
Figure 30. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Region (2017-2028)
Figure 31. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Region (2017-2028)
Figure 32. North America Proto Oncogene Tyrosine Protein Kinase Src Revenue (2017-2028) & (USD Million)
Figure 33. Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue (2017-2028) & (USD Million)
Figure 34. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue (2017-2028) & (USD Million)
Figure 35. South America Proto Oncogene Tyrosine Protein Kinase Src Revenue (2017-2028) & (USD Million)
Figure 36. Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue (2017-2028) & (USD Million)
Figure 37. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Type (2017-2028)
Figure 38. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Type (2017-2028)
Figure 39. Global Proto Oncogene Tyrosine Protein Kinase Src Price by Type (2017-2028) & (US$/Unit)
Figure 40. Global Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2017-2028)
Figure 41. Global Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Application (2017-2028)
Figure 42. Global Proto Oncogene Tyrosine Protein Kinase Src Price by Application (2017-2028) & (US$/Unit)
Figure 43. North America Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Type (2017-2028)
Figure 44. North America Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2017-2028)
Figure 45. North America Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Country (2017-2028)
Figure 46. North America Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Country (2017-2028)
Figure 47. United States Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Type (2017-2028)
Figure 51. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2017-2028)
Figure 52. Europe Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Country (2017-2028)
Figure 53. Europe Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Country (2017-2028)
Figure 54. Germany Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Region (2017-2028)
Figure 63. China Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Korea Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Type (2017-2028)
Figure 70. South America Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2017-2028)
Figure 71. South America Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Country (2017-2028)
Figure 72. South America Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Type (2017-2028)
Figure 76. Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Application (2017-2028)
Figure 77. Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Sales Market Share by Region (2017-2028)
Figure 78. Middle East & Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue Market Share by Region (2017-2028)
Figure 79. Turkey Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Egypt Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. South Africa Proto Oncogene Tyrosine Protein Kinase Src Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Manufacturing Cost Structure Analysis of Proto Oncogene Tyrosine Protein Kinase Src in 2021
Figure 84. Manufacturing Process Analysis of Proto Oncogene Tyrosine Protein Kinase Src
Figure 85. Proto Oncogene Tyrosine Protein Kinase Src Industrial Chain
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Figure 87. Methodology
Figure 88. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のチロシンプロテインキナーゼマー市場2022年：市場規模予測（～2028年）
  • チロシンタンパク質ホスファターゼ非受容体タイプ 1のグローバル市場展望 2023年-2029年：AU-2439、CPT-157633、DPM-1001、KQ-791、その他
  • 世界のミトジェン活性化プロテインキナーゼ（MAPK）9市場2022年：市場規模予測（～2028年）
  • Rho関連プロテインキナーゼ1のグローバル市場展望 2023年-2029年：AN-3485、KL-01045、AT-13148、TRX-101、その他
  • プロテインキナーゼCモジュレーターのグローバル市場展望 2023年-2029年：タブレット、ジェル、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19578 )"世界のプロトオンコジーンチロシンプロテインキナーゼSrc市場2022年：市場規模予測（～2028年）" (英文：Global Proto Oncogene Tyrosine Protein Kinase Src Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。